Cargando…
ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma
BACKGROUND: Thyroid carcinoma (TC) is the most common malignant endocrine tumor worldwide. Several studies have documented that male patients with TC have a higher rate of metastasis and disease recurrence than female patients. However, the mechanism underlying this observation is not completely cle...
Autores principales: | Qiu, Weigang, Wu, Xinquan, Shi, Haihong, Liu, Bingyang, Li, Liqiong, Wu, Wenyi, Lin, Jianqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841667/ https://www.ncbi.nlm.nih.gov/pubmed/35174076 http://dx.doi.org/10.3389/fonc.2022.678025 |
Ejemplares similares
-
A two-microRNA signature predicts the progression of male thyroid cancer
por: Liu, Bingyang, et al.
Publicado: (2021) -
Erratum to “A two-microRNA signature predicts the progression of male thyroid cancer”
por: Liu, Bingyang, et al.
Publicado: (2022) -
Comprehensive Analysis Identified ASF1B as an Independent Prognostic Factor for HBV-Infected Hepatocellular Carcinoma
por: Wang, Xianmo, et al.
Publicado: (2022) -
Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-Environment
por: Ma, Jing, et al.
Publicado: (2021) -
ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types
por: Zhang, Wencheng, et al.
Publicado: (2021)